Equity Capital Markets

Company · CIK 2096997

Kailera Therapeutics, Inc.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

CIK2096997 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
ListedKLRA (Nasdaq)
First annual or quarterly report2026-05-26

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-294690
IPOFinal prospectus
 2026-03-272026-04-174

Filings

5
FiledFilingRegistrationAccession
2026-04-17424B4Final prospectus 333-2946900001193125-26-161521
2026-04-16EFFECTDeclared effective 333-2946909999999995-26-001217
2026-04-13S-1/AAmendment 333-2946900001193125-26-151904
2026-03-27S-1Registration filed 333-2946900001193125-26-128952
2025-12-19DRSDraft made public 377-088410001193125-25-326849

All filings of this company · CSV